Literature DB >> 7131714

A trial procedure to prevent aneurysm formation of the coronary arteries by steroid pulse therapy in Kawasaki disease.

Y Kijima, T Kamiya, A Suzuki, O Hirose, H Manabe.   

Abstract

Sixty patients with Kawasaki disease in the acute phase were studied using a two-dimensional echocardiography. Coronary lesions in Kawasaki disease were characterized echocardiographically by an increase of echo density of the coronary artery and by dilatation or aneurysm of the coronary artery. These findings appeared in the sequence mentioned above in patients who were studied serially. In the group treated with corticosteroid, 62% of the patients showed a disappearance or an improvement of the coronary dilatation or aneurysm, while only 33% of untreated patients showed such an improvement. In patients with coronary aneurysms on the initial echocardiogram, 53% of the pulse therapy group showed an improvement, but none of the untreated group did. A similar result was obtained by an analysis of its therapeutical effect, according to the number of vessels involved. Thus, corticosteroid pulse therapy was shown to be effective for the prevention of coronary arterial aneurysms in Kawasaki disease, if it was given in a sufficient dose in the acute phase of this disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7131714     DOI: 10.1253/jcj.46.1239

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  18 in total

Review 1.  Use of corticosteroids during acute phase of Kawasaki disease.

Authors:  Jeong Jin Yu
Journal:  World J Clin Pediatr       Date:  2015-11-08

Review 2.  Overview of pharmacological treatment of Kawasaki disease.

Authors:  Z Onouchi; T Kawasaki
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

Review 3.  Pharmacological therapy for patients with Kawasaki disease.

Authors:  R V Williams; L L Minich; L Y Tani
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 4.  Treatment Options for Resistant Kawasaki Disease.

Authors:  Linny Kimly Phuong; Nigel Curtis; Peter Gowdie; Jonathan Akikusa; David Burgner
Journal:  Paediatr Drugs       Date:  2018-02       Impact factor: 3.022

5.  A case of refractory Kawasaki disease complicated by peripheral ischemia.

Authors:  Na Yeon Kim; Deok Young Choi; Mi Jin Jung; In-Sang Jeon
Journal:  Pediatr Cardiol       Date:  2008-05-15       Impact factor: 1.655

6.  Kawasaki disease at British Columbia's Children's Hospital.

Authors:  Regan L Ebbeson; Mark R Riley; Jim E Potts; Derek G Human; Peter N Malleson
Journal:  Paediatr Child Health       Date:  2004-09       Impact factor: 2.253

Review 7.  Kawasaki disease: an update.

Authors:  Abraham Gedalia
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.686

Review 8.  Corticosteroid therapy for primary treatment of Kawasaki disease - weight of evidence: a meta-analysis and systematic review of the literature.

Authors:  Ganesh Athappan; Seth Gale; Thirumalaikolundusubramanian Ponniah
Journal:  Cardiovasc J Afr       Date:  2009 Jul-Aug       Impact factor: 1.167

9.  Kawasaki disease.

Authors:  Jane W Newburger; David R Fulton
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-04

Review 10.  Medium-size-vessel vasculitis.

Authors:  Michael J Dillon; Despina Eleftheriou; Paul A Brogan
Journal:  Pediatr Nephrol       Date:  2009-11-28       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.